KOPRAN Quarterly Results
| Consolidated | Dec2025 UnAudited |
Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹194 Cr | ₹118 Cr | ₹135 Cr | ₹172 Cr | ₹166 Cr | ₹152 Cr | ₹139 Cr | ₹186 Cr |
| Expenses | ₹177 Cr | ₹123 Cr | ₹121 Cr | ₹155 Cr | ₹146 Cr | ₹137 Cr | ₹121 Cr | ₹164 Cr |
| Operating Income | ₹18 Cr | ₹-5 Cr | ₹14 Cr | ₹17 Cr | ₹20 Cr | ₹15 Cr | ₹18 Cr | ₹22 Cr |
| Other Income | ₹0 Cr | ₹0 Cr | ₹3 Cr | ₹3 Cr | ₹0 Cr | ₹1 Cr | ₹3 Cr | ₹10 Cr |
| Interest | ₹3 Cr | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr |
| Depreciation | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr |
| Profit Before Tax | ₹11 Cr | ₹-12 Cr | ₹10 Cr | ₹14 Cr | ₹14 Cr | ₹10 Cr | ₹15 Cr | ₹25 Cr |
| Profit After Tax | ₹9 Cr | ₹-10 Cr | ₹7 Cr | ₹10 Cr | ₹10 Cr | ₹7 Cr | ₹11 Cr | ₹19 Cr |
| EPS | ₹1.93 | ₹-2.06 | ₹1.54 | ₹2.00 | ₹2.15 | ₹1.53 | ₹2.30 | ₹3.86 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| KOPRAN | -5.4% | -8.1% | -25.7% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.4% | -0.1% | -2% |
| DIVIS LABORATORIES | 0.9% | -3% | 0.8% |
| CIPLA | -0.9% | -7.2% | -9.7% |
| TORRENT PHARMACEUTICALS | 2% | 1.7% | 25.2% |
| DR REDDYS LABORATORIES | -0.6% | 6.8% | 2.7% |
| MANKIND PHARMA | -1.1% | -8.2% | -17.5% |
| ZYDUS LIFESCIENCES | -2% | 2.4% | -7.4% |
| LUPIN | 0% | 0.2% | 0.5% |
KOPRAN Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 64.77 % |
| Y-o-Y | 16.87 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Dec2025 | ₹194 Cr | 64.77 | |
| Sep2025 | ₹118 Cr | -12.80 | |
| Jun2025 | ₹135 Cr | -21.55 | |
| Mar2025 | ₹172 Cr | 3.68 | |
| Dec2024 | ₹166 Cr | 9.69 | |
| Sep2024 | ₹152 Cr | 8.70 | |
| Jun2024 | ₹139 Cr | -25.07 | |
| Mar2024 | ₹186 Cr | - | |
KOPRAN Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | Positive |
| Y-o-Y | -10.46 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Dec2025 | ₹18 Cr | Positive | |
| Sep2025 | ₹-5 Cr | Negative | |
| Jun2025 | ₹14 Cr | -17.31 | |
| Mar2025 | ₹17 Cr | -13.87 | |
| Dec2024 | ₹20 Cr | 34.60 | |
| Sep2024 | ₹15 Cr | -18.85 | |
| Jun2024 | ₹18 Cr | -16.27 | |
| Mar2024 | ₹22 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | Positive |
| Y-o-Y | -23.39 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Dec2025 | 9.14% | Positive | |
| Sep2025 | -4.48% | Negative | |
| Jun2025 | 10.45% | 5.45 | |
| Mar2025 | 9.91% | -16.93 | |
| Dec2024 | 11.93% | 22.74 | |
| Sep2024 | 9.72% | -25.40 | |
| Jun2024 | 13.03% | 11.75 | |
| Mar2024 | 11.66% | - | |
KOPRAN Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | Positive |
| Y-o-Y | -10.13 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Dec2025 | ₹9 Cr | Positive | |
| Sep2025 | ₹-10 Cr | Negative | |
| Jun2025 | ₹7 Cr | -23.02 | |
| Mar2025 | ₹10 Cr | -6.89 | |
| Dec2024 | ₹10 Cr | 40.76 | |
| Sep2024 | ₹7 Cr | -33.44 | |
| Jun2024 | ₹11 Cr | -40.42 | |
| Mar2024 | ₹19 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | Positive |
| Y-o-Y | -23.04 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Dec2025 | 4.81 % | Positive | |
| Sep2025 | -8.42 % | Negative | |
| Jun2025 | 5.51 % | -1.78 | |
| Mar2025 | 5.61 % | -10.24 | |
| Dec2024 | 6.25 % | 28.34 | |
| Sep2024 | 4.87 % | -38.82 | |
| Jun2024 | 7.96 % | -20.48 | |
| Mar2024 | 10.01 % | - | |
KOPRAN Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | Positive |
| Y-o-Y | -10.23 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Dec2025 | ₹1.93 | Positive | |
| Sep2025 | ₹-2.06 | Negative | |
| Jun2025 | ₹1.54 | -23.00 | |
| Mar2025 | ₹2 | -6.98 | |
| Dec2024 | ₹2.15 | 40.52 | |
| Sep2024 | ₹1.53 | -33.48 | |
| Jun2024 | ₹2.3 | -40.41 | |
| Mar2024 | ₹3.86 | - | |
You may also like the below Video Courses
Check out Intrinsic Value of Industry Peers of KOPRAN
